{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T03:37:08Z","timestamp":1784432228541,"version":"3.55.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2022.13513","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T11:17:28Z","timestamp":1663759048000},"source":"Crossref","is-referenced-by-count":6,"title":["Combined treatment with radiotherapy, chemotherapy and avelumab results in regression of metastatic Merkel cell carcinoma and improvement of associated Lambert\u2011Eaton myasthenic syndrome: A case report"],"prefix":"10.3892","volume":"24","author":[{"given":"Caroline","family":"Green","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Ume\u00e5 University, SE\u201190187 Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Mett\u00e4vainio","sequence":"additional","affiliation":[{"name":"Department of Medical Biosciences, Ume\u00e5 University, SE\u201190187 Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kjellman","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Ume\u00e5 University, SE\u201190187 Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torbj\u00f6rn","family":"Ramqvist","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institute, SE\u201117177 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dalianis","sequence":"additional","affiliation":[{"name":"Department of Oncology\u2011Pathology, Karolinska Institute, SE\u201117177 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Israelsson","sequence":"additional","affiliation":[{"name":"Department of Radiation Sciences, Ume\u00e5 University, SE\u201190187 Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lindquist","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Ume\u00e5 University, SE\u201190187 Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"key20221013104750_b1-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/00000372-198412000-00002","article-title":"New immunocytochemical observations with diagnostic significance in cutaneous neuroendocrine carcinoma","volume":"6","author":"Hoefler","year":"1984","journal-title":"Am J Dermatopathol"},{"key":"key20221013104750_b2-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1053\/hupa.2001.25904","article-title":"Primary neuroendocrine (Merkel cell) carcinoma of the skin: Morphologic diversity and implications thereof","volume":"32","author":"Walsh","year":"2001","journal-title":"Hum Pathol"},{"key":"key20221013104750_b3-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"17077","DOI":"10.1038\/nrdp.2017.77","article-title":"Merkel cell carcinoma","volume":"3","author":"Becker","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"key20221013104750_b4-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/mus.25530","article-title":"Paraneoplastic cerebellar degeneration and lambert-eaton myasthenia in a patient with merkel cell carcinoma and voltage-gated calcium channel antibodies","volume":"56","author":"Pavolucci","year":"2017","journal-title":"Muscle Nerve"},{"key":"key20221013104750_b5-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4065\/76.3.327","article-title":"Paraneoplastic and metastatic neurologic complications of Merkel cell carcinoma","volume":"76","author":"Eggers","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"key20221013104750_b6-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: A multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol"},{"key":"key20221013104750_b7-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1080\/21645515.2018.1551671","article-title":"Product review: Avelumab, an anti-PD-L1 antibody","volume":"15","author":"Collins","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"key20221013104750_b8-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ncl.2018.01.008","article-title":"Lambert-eaton myasthenic syndrome","volume":"36","author":"Kesner","year":"2018","journal-title":"Neurol Clin"},{"key":"key20221013104750_b9-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/brain\/111.3.577","article-title":"The lambert-eaton myasthenic syndrome. A review of 50 cases","volume":"111","author":"O'Neill","year":"1988","journal-title":"Brain"},{"key":"key20221013104750_b10-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/j.1468-1331.2010.03019.x","article-title":"Guidelines for treatment of autoimmune neuromuscular transmission disorders","volume":"17","author":"Skeie","year":"2010","journal-title":"Eur J Neurol"},{"key":"key20221013104750_b11-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2217\/fvl.13.55","article-title":"Human polyomaviruses were not detected in cerebrospinal fluid of patients with neurological complications after hematopoietic stem cell transplantation","volume":"8","author":"Gustafsson","year":"2013","journal-title":"Future Virol"},{"key":"key20221013104750_b12-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1365-2559.2005.02158.x","article-title":"Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers","volume":"46","author":"Llombart","year":"2005","journal-title":"Histopathology"},{"key":"key20221013104750_b13-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"964e3","DOI":"10.1016\/j.jaad.2017.11.037","article-title":"Differentiating Merkel cell carcinoma of lymph nodes without a detectable primary skin tumor from other metastatic neuroendocrine carcinomas: The ELECTHIP criteria","volume":"78","author":"Kervarrec","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"key20221013104750_b14-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000443172","article-title":"ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas","volume":"103","author":"Garcia-Carbonero","year":"2016","journal-title":"Neuroendocrinology"},{"key":"key20221013104750_b15-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.humpath.2011.01.020","article-title":"Recent advances in the biology of Merkel cell carcinoma","volume":"42","author":"Kuwamoto","year":"2011","journal-title":"Hum Pathol"},{"key":"key20221013104750_b16-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"key20221013104750_b17-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/jnci\/djp375","article-title":"Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma","volume":"101","author":"Sihto","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"key20221013104750_b18-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1097\/PAS.0b013e3181ba7b73","article-title":"Merkel cell polyomavirus: A specific marker for Merkel cell carcinoma in histologically similar tumors","volume":"33","author":"Duncavage","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"key20221013104750_b19-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/00000478-200009000-00004","article-title":"Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas","volume":"24","author":"Ordonez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"key20221013104750_b20-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13550-018-0423-3","article-title":"(18)F-FDG and (68)Ga-somatostatin analogs PET\/CT in patients with Merkel cell carcinoma: A comparison study","volume":"8","author":"Taralli","year":"2018","journal-title":"EJNMMI Res"},{"key":"key20221013104750_b21-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/cells9061376","article-title":"PD-1: Its discovery, involvement in cancer immunotherapy, and beyond","volume":"9","author":"Ishida","year":"2020","journal-title":"Cells"},{"key":"key20221013104750_b22-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"327150","DOI":"10.1155\/2013\/327150","article-title":"Merkel cell carcinoma: Chemotherapy and emerging new therapeutic options","volume":"2013","author":"Desch","year":"2013","journal-title":"J Skin Cancer"},{"key":"key20221013104750_b23-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s42466-020-00099-5","article-title":"Immunoglobulins to mitigate paraneoplastic lambert eaton myasthenic syndrome under checkpoint inhibition in Merkel cell carcinoma","volume":"2","author":"Dohrn","year":"2020","journal-title":"Neurol Res Pract"},{"key":"key20221013104750_b24-ol-24-05-13513","first-page":"adv00452","article-title":"Lambert-eaton myasthenic syndrome and paraneoplastic cerebellar degeneration associated with merkel cell carcinoma with unknown primary: A case report","volume":"101","author":"Agostini","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"key20221013104750_b25-ol-24-05-13513","first-page":"E19","article-title":"Lambert-Eaton myasthenic syndrome and merkel cell carcinoma","volume":"103","author":"Nguyen","year":"2019","journal-title":"Cutis"},{"key":"key20221013104750_b26-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jaad.2016.04.040","article-title":"Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations","volume":"75","author":"Iyer","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"key20221013104750_b27-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s10072-015-2107-3","article-title":"Lambert-Eaton myasthenic syndrome associated to Merkel cell carcinoma: Report of a case","volume":"36","author":"Bombelli","year":"2015","journal-title":"Neurol Sci"},{"key":"key20221013104750_b28-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1120009X.2022.2073162","article-title":"Lambert-Eaton myasthenic syndrome (LEMS) in a patient with lung cancer under treatment with pembrolizumab: A case study","volume":"13","author":"Lee","year":"2022","journal-title":"J Chemother"},{"key":"key20221013104750_b29-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1016\/j.cllc.2021.09.001","article-title":"An extensive-stage small-cell lung cancer case with preexisting lambert-eaton myasthenic syndrome successfully treated with an immune checkpoint inhibitor","volume":"23","author":"Sakaguchi","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"key20221013104750_b30-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1002\/mus.27141","article-title":"Nivolumab-associated lambert-eaton myasthenic syndrome and cerebellar dysfunction in a patient with a neuroendocrine tumor","volume":"63","author":"Gill","year":"2021","journal-title":"Muscle Nerve"},{"key":"key20221013104750_b31-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.2169\/internalmedicine.8387-21","article-title":"Lambert-eaton myasthenic syndrome caused by atezolizumab in a patient with small-cell lung cancer","volume":"61","author":"Kunii","year":"2022","journal-title":"Intern Med"},{"key":"key20221013104750_b32-ol-24-05-13513","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1159\/000494078","article-title":"Lambert-eaton myasthenic syndrome caused by nivolumab in a patient with squamous cell lung cancer","volume":"10","author":"Nakatani","year":"2018","journal-title":"Case Rep Neurol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T07:47:56Z","timestamp":1665647276000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,9,21]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2022.13513","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"article-number":"393"}}